Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors

By IT Hygieia | May 2, 2023

Livonia, Mich., May 2, 2023 – Hygieia, a digital therapeutics company for insulin therapy, is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.   Hygieia is the maker of d-Nav®, the only FDA-cleared technology to autonomously adjust insulin dose recommendations to…

Read More